Lung Cancer

Chemotherapy and Predictive Markers

Chemotherapy and Predictive Markers

The Evolving Role of Chemotherapy and Predictive Markers in Early-stage Non-small-cell Lung Cancer

Eric W Humke, Heather Wakelee

European Oncology & Haematology, 2011;7(2):109-115

Improving Survival Rates

Improving Survival Rates

Diagnosis of Lung Cancer – Improving Survival Rates

Victoria L Athey, Angela M Tod, Rupert Suckling, Trevor Rogers

European Oncology, 2010;6(2):26-30

Evolving Role of Chemotherapy

Evolving Role of Chemotherapy

The Evolving Role of Chemotherapy and Predictive Markers in Early-stage Non-small-cell Lung Cancer

Eric W Humke, Heather Wakelee

European Oncology & Haematology, 2011;7(2):109-115

Diagnosis of Lung Cancer

Diagnosis of Lung Cancer

Diagnosis of Lung Cancer – Improving Survival Rates

Victoria L Athey, Angela M Tod, Rupert Suckling, Trevor Rogers

European Oncology, 2010;6(2):26-30

Editor's choice

Lung Cancer
Second- and Third-line Treatment in Advanced Non-small-cell Lung Cancer
Adolfo Favaretto et al.
European Oncology & Haematology, 2009;5(1):38-40

Also in Editor's Choice

Second- and Third-line Treatment in Advanced Non-small-cell Lung Cancer

Latest Articles

Concurrent Chemoradiation in Inoperable, Locally Advanced Non-small Cell Lung Cancer – Comparison of Efficacy and Toxicity in the Elderly
Christine Collen, Denis Schallier, Mark De Ridder
A Review of Treatment in Non-small-cell Lung Cancer
Athanasios G Pallis
The Evolving Role of Chemotherapy and Predictive Markers in Early-stage Non-small-cell Lung Cancer
Eric W Humke, Heather Wakelee
The Challenge of Mediastinal Staging
Loris Ceron, Lucio Michieletto, Andrea Zamperlin, Laura Mancino
Diagnosis of Lung Cancer – Improving Survival Rates
Victoria L Athey, Angela M Tod, Rupert Suckling, Trevor Rogers
all articles >
close

This content is copyright protected

However, if you would like to share the information on this webpage, you may use the headline and link below:

Lung Cancer

Read more: Lung Cancer